January 11, 2013

FDA seeks staff fellow for hepatitis C research


Published on January 11, 2013 by Bryan Cohen

The U.S. Food and Drug Administration’s Center for Biologics Evaluation & Research recently announced a new position for a staff fellow within its Laboratory of Hepatitis Viruses.

The position, which will fall under the Office of Vaccines Research and Review, will perform novel research using mouse model systems to support hepatitis virus replication. The LHV is currently engaged in research on the molecular biology of the hepatitis virus, particularly studies related to vaccine for the hepatitis C virus.

The fellow will be required to perform regulatory review such as product chemistry, manufacturing and control and validation, and review of clinical protocols, in addition to review of experimental and licensed hepatitis virus vaccines.

According to the Centers for Disease Control and Prevention, hepatitis C is a contagious liver disease caused by infection with the hepatitis C virus. The disease can range in severity from a mild illness that lasts a few weeks to a chronic and more serious illness.

Acute hepatitis C virus infection can lead to chronic infection. When the hepatitis C virus remains in a person’s body, it can cause serious liver problems, scarring of the liver or liver cancer.

The fellow position will first be located on the National Institutes of Health campus in Bethesda, Md., and will be relocated to the FDA’s White Oak campus in Silver Spring, Md. in mid-2014.

This story filed in FDA and tagged Hepatitis.


No comments:

Post a Comment